Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
ES
EN
0,00
€
0
Cart
TOC Alert
Review Articles
RNA Helicase Involvement in HIV-1 Rev Export
HIV Chemotherapy Revisited
Liver Toxicity is not Increased with Nevirapine Once a Day
48-Weeks Results of the RESIST Trials
Outbreaks of Acute Hepatitis C Among HIV+ Homosexual Men in Europe
Results of the KLEAN Study
Nevirapine-Associated Hepatotoxicity in Virologically Suppressed Patients – Role of Gender and CD4+ Cell Counts
SPRING: A New Trial to Evaluate Tipranavir in Heterogeneous Treatment-Experienced HIV Populations
The NEFA Study: Results at Three Years
Three-year Extended Follow-up of the 2NN Study: Nevirapine versus Efavirenz